as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
1.12%
Downside
2.10%
Upside
52 Week's Low
52 Week's High
61.43%
Downside
33.50%
Upside
Check Guardant Health, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$12.0B
EPS (TTM)
-1.5574
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.5
Industry PE ratio
7.871681415929204
PEG Ratio
0EBITDA
-396.6M
Revenue (TTM)
982.0M
Profit Margin
-42.39%
Return On Equity TTM
-4584.47%
Track how Guardant Health, Inc. P/E has moved over time to understand its valuation trends.
Guardant Health, Inc. in the last 5 years
Lowest (-49.15x)
December 31, 2025
Today (-6.50x)
March 10, 2026
Industry (7.87x)
March 10, 2026
Highest (-5.35x)
March 31, 2023
Today’s Price to Earnings Ratio: -6.50x
Compare market cap, revenue, PE, and other key metrics of Guardant Health, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $12.0B | -33.28% | -6.5 | -42.39% | |
| BUY | $48.6B | 24.89% | 46.51 | 24.62% | |
| BUY | $186.5B | 15.62% | 28.33 | 15.05% | |
| BUY | $30.4B | -5.9% | 22.8 | 8.34% | |
| BUY | $33.0B | -2.79% | 25.75 | 18.26% |
The Guardant Health, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Guardant Health, Inc. investment value today
Current value as on today
₹2,57,536
Returns
₹1,57,536
(+157.54%)
Returns from Guardant Health, Inc. Stock
₹1,52,344 (+152.34%)
Dollar Returns*
₹5,192 (+5.19%)
Based on 30 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 30 analysts, 83.33% of analysts recommend a 'BUY' rating for Guardant Health, Inc.. Average target price of $132.57
Get share price movements and forecasts by analysts on Guardant Health, Inc..
What analysts predicted
31.78%UPSIDE
Target Price
$132.57
Current Price
$90.44
Analyzed by
30 Analysts
Target
$132.57
Guardant Health, Inc. target price $132.57, a slight upside of 31.78% compared to current price of $90.44. According to 30 analysts rating.
Search interest for Guardant Health, Inc. Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 March
Thu, 10:21 PM
-Guardant Health strengthens its position in liquid biopsy market with advanced genomic testing and FDA-approved colorectal cancer screening test Shield.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 16 quarters, 96.09M → 281.26M (in $), with an average increase of 6.9% per quarter
Best in 1 Year
![]()
In the last 1 year, GH has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, GH has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 6 months, GH stock has moved up by 61.2%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -92.72M → -128.49M (in $), with an average decrease of 38.6% per quarter
| Organisation | Guardant Health, Inc. |
| Headquarters | 3100 Hanover Street, Palo Alto, CA, United States, 94304 |
| Industry | Health Services |
| CEO | Dr. Helmy Eltoukhy Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Terilyn Juarez Monroe | Chief People Officer |
Mr. Kumud Kalia | Chief Information Officer |
Zarak Khurshid | Vice President of Investor Relations |
Ms. Gulshan Shaver J.D. | Senior VP of Legal Affairs & Chief Compliance Officer |
Mr. Michael Bell | Chief Financial Officer |
Mr. John G. Saia J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Darya Chudova | Chief Technology Officer |
Mr. Andy Ament | Senior Vice President of Operations |
Dr. Helmy Eltoukhy Ph.D. | Co-Founder, Co-CEO & Chairman |
Dr. AmirAli Talasaz Ph.D. | Co-CEO & Director |
Guardant Health, Inc. share price today is $90.44 as on . Guardant Health, Inc. share today touched a day high of $92.34 and a low of $89.43.
Guardant Health, Inc. share touched a 52 week high of $120.74 on and a 52 week low of $34.88 on . Guardant Health, Inc. stock price today i.e. is trending at $90.44,which is 25.10% down from its 52 week high and 159.29% up from its 52 week low.
Guardant Health, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Guardant Health, Inc. (GH) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Guardant Health, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Guardant Health, Inc. share’s latest price of $90.44 as on March 11, 2026 at 1:29 am IST, you will get 0.1106 shares of Guardant Health, Inc.. Learn more about
fractional shares .
Guardant Health, Inc. stock has given -33.28% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?